Antibody Library Technology Market Key Drivers and Challenges in the Industry

Antibody library technology has revolutionized drug discovery by enabling the rapid identification and development of therapeutic antibodies. With the increasing demand for targeted therapies, this technology has become an essential tool in modern drug development. Innovations in display techniques, screening methodologies, and computational approaches have enhanced the efficiency of antibody discovery, paving the way for new treatment options in various diseases. The global antibody library technology market is anticipated to reach a size of US$ 1.7 Bn by 2025. It is set to showcase a CAGR of 4.1% during the forecast period to attain a value of US$ 2.2 Bn by 2032. Rare and orphan diseases are estimated to witness exponential growth during the forecast period with over 20% of new therapeutic antibodies addressing orphan indications by 2030. Understanding Antibody Library Technology Antibody library technology involves generating vast collections of antibody variants that can be screened to identify candidates with high specificity and affinity for target antigens. These libraries are created using different display platforms, including phage display, ribosome display, yeast display, and mammalian cell display. By utilizing these approaches, researchers can select and optimize antibodies for therapeutic applications, diagnostics, and research. Innovations in Antibody Display Technologies Phage Display Advancements